Standout Papers

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. 1997 2026 2006 2016 523
  1. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. (1997)
    W ten Bokkel Huinink, Martin Gore et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
1 intermediate paper

Works of C Scarabelli being referenced

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
1997 Standout
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
1997

Author Peers

Author Last Decade Papers Cites
C Scarabelli 650 464 342 37 948
Enrico Breda 702 357 353 38 956
Giuseppe Scaletta 489 281 428 46 991
A. Graf 414 215 313 30 810
Trudy R. Baker 631 311 406 31 862
Harushige Yokota 668 366 467 33 1.1k
Sheldon Weiner 496 240 439 29 902
Charles E. Welander 355 193 243 36 856
Ming-Shyen Yen 490 367 500 49 1.1k
Kristin Bixel 408 163 344 68 828
Simon Butler‐Manuel 342 267 399 62 992

All Works

Loading papers...

Rankless by CCL
2026